Related Experiment Video
Updated: Mar 25, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Evaluation of the Bioavailability and Metabolism of Nitroderivatives of Hydroxytyrosol Using Caco-2 and HepG2 Human
Elena Gallardo1,2,3, Beatriz Sarria1, José Luis Espartero2
1Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), CSIC , Madrid, Spain.
Abstract:
Considering that nitrocatechols present putative effects against Parkinson's disease, the absorption and metabolism of nitroderivatives of hydroxytyrosol (HT) were assessed using human cell model systems. The test compounds nitrohydroxytyrosol (NO2HT), nitrohydroxytyrosyl acetate (NO2HT-A), and ethyl nitrohydroxytyrosyl ether (NO2HT-E) were efficiently transferred across human Caco-2 cell monolayers as an intestinal barrier model, NO2HT-A and NO2HT-E being better (p < 0.05) absorbed (absorption rate (AR) = 1.4 ± 0.1 and 1.5 ± 0.2, respectively) than their precursor, NO2HT (AR = 1.1 ± 0.1). A significant amount of the absorbed compounds remained unconjugated (81, 70, and 33% for NO2HT, NO2HT-A, and NO2HT-E, respectively) after incubation in Caco-2 cells, being available for hepatic metabolism. Nitrocatechols were extensively taken up and metabolized by human hepatoma HepG2 cells as a model of the human liver. Both studies revealed extensive hydrolysis of NO2HT-A into NO2HT, whereas NO2HT-E was not hydrolyzed. Glucuronide (75-55%), methylglucuronide (25-33%), and methyl derivatives (0-12%) were the main nitrocatechol metabolites detected after metabolism in Caco-2 and HepG2 cells. In conclusion, NO2HT, NO2HT-A, and NO2HT-E show high in vitro bioavailability and are extensively metabolized by hepatic cells.
Insights
Nitrohydroxytyrosol derivatives show promising absorption and metabolism in human cell models, suggesting potential for Parkinson's disease treatment. These compounds are efficiently absorbed and extensively metabolized by liver cells.
Area of Science:
- Pharmacology and Toxicology
- Cell Biology
- Neuroscience
Background:
- Nitrocatechols are being investigated for potential therapeutic effects against Parkinson's disease.
- Hydroxytyrosol (HT) derivatives, specifically nitroderivatives, require assessment for their pharmacokinetic properties.
Purpose of the Study:
- To evaluate the absorption and metabolism of nitrohydroxytyrosol (NO2HT) and its derivatives (NO2HT-A, NO2HT-E) in human in vitro models.
- To determine the bioavailability and metabolic pathways of these compounds in intestinal and hepatic cell systems.
Main Methods:
- Utilized human Caco-2 cell monolayers to model intestinal absorption.
- Employed human hepatoma HepG2 cells to simulate hepatic metabolism.
- Quantified compound absorption rates and identified major metabolites (glucuronides, methylglucuronides, methyl derivatives).
Main Results:
- NO2HT-A and NO2HT-E demonstrated superior absorption across Caco-2 cells compared to NO2HT.
- Significant amounts of absorbed compounds remained unconjugated, indicating availability for hepatic processing.
- HepG2 cells extensively metabolized nitrocatechols, with NO2HT-A being hydrolyzed to NO2HT, while NO2HT-E remained intact.
- Glucuronide and methylglucuronide conjugates were the primary metabolites identified.
Conclusions:
- NO2HT, NO2HT-A, and NO2HT-E exhibit high in vitro bioavailability.
- These nitroderivatives undergo extensive metabolism in hepatic cells, forming various conjugates.
- The findings support the potential of these nitrocatechols as candidates for Parkinson's disease therapeutics.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability: Influencing Factors
Bioavailability: Overview

